Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries
Peh Joo Ho, Christine Kim Yan Loo, Meng Huang Goh, Mustapha Abubakar, Thomas U. Ahearn, Irene L. Andrulis, Natalia N. Antonenkova, Kristan J. Aronson, Annelie Augustinsson, Sabine Behrens, Clara Bodelon, Natalia V. Bogdanova, Manjeet K. Bolla, Kristen Brantley, Hermann Brenner, Helen Byers, Nicola J. Camp, Jose E. Castelao, Melissa H. Cessna, Jenny Chang-Claude, Stephen J. Chanock, Georgia Chenevix-Trench, Ji-Yeob Choi, Sarah V. Colonna, Kamila Czene, Mary B. Daly, Francoise Derouane, Thilo Dörk, A. Heather Eliassen, Christoph Engel, Mikael Eriksson, D. Gareth Evans, Olivia Fletcher, Lin Fritschi, Manuela Gago-Dominguez, Jeanine M. Genkinger, Willemina R.R. Geurts-Giele, Gord Glendon, Per Hall, Ute Hamann, Cecilia Y.S. Ho, Weang-Kee Ho, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, ABCTB Investigators, kConFab Investigators, SGBCC Investigators, MyBrCa Investigators, Hidemi Ito, Motoki Iwasaki, Anna Jakubowska, Helena Jernström, Esther M. John, Nichola Johnson, Daehee Kang, Sung-Won Kim, Cari M. Kitahara, Yon-Dschun Ko, Peter Kraft, Ava Kwong, Diether Lambrechts, Susanna Larsson, Shuai Li, Annika Lindblom, Martha Linet, Jolanta Lissowska, Artitaya Lophatananon, Robert J. MacInnis, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, Keitaro Matsuo, Kyriaki Michailidou, Roger L. Milne, Nur Aishah Mohd Taib, Kenneth Muir, Rachel A. Murphy, William G. Newman, Katie M. O’Brien, Nadia Obi, Olufunmilayo I. Olopade, Mihalis I. Panayiotidis, Sue K. Park, Tjoung-Won Park-Simon, Alpa V. Patel, Paolo Peterlongo, Dijana Plaseska-Karanfilska, Katri Pylkäs, Muhammad U. Rashid, Gad Rennert, Juan Rodriguez, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Christopher G. Scott, Shamim Shahi, Xiao-Ou Shu, Katerina Shulman, Jacques Simard, Melissa C. Southey, Jennifer Stone, Jack A. Taylor, Soo-Hwang Teo, Lauren R. Teras, Mary Beth Terry, Diana Torres, Celine M. Vachon, Maxime Van Houdt, Jelle Verhoeven, Clarice R. Weinberg, Alicja Wolk, Taiki Yamaji, Cheng Har Yip, Wei Zheng, Mikael Hartman, Jingmei Li
doi: https://doi.org/10.1101/2025.02.27.25323002
Peh Joo Ho
1Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore City, 138672
2Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore City, 117549
PhDChristine Kim Yan Loo
1Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore City, 138672
Meng Huang Goh
1Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore City, 138672
Mustapha Abubakar
3Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA, Bethesda, MD, 20850
Thomas U. Ahearn
3Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA, Bethesda, MD, 20850
PhDIrene L. Andrulis
4Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Canada, Toronto, Ontario, M5G 1X5
5Department of Molecular Genetics, University of Toronto, Canada, Toronto, Ontario, M5S 1A8
PhDNatalia N. Antonenkova
6N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Belarus, Minsk, 223040
MDKristan J. Aronson
7Department of Public Health Sciences, and Sinclair Cancer Research Institute, Queen’s University, Canada, Kingston, ON, K7L 3N6
PhDAnnelie Augustinsson
8Oncology, Department of Clinical Sciences in Lund, Lund University, Sweden, Lund, 221 85
PhDSabine Behrens
9Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany, Heidelberg, 69120
Clara Bodelon
10Department of Population Science, American Cancer Society, USA, Atlanta, GA, 30303
Natalia V. Bogdanova
6N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Belarus, Minsk, 223040
11Department of Radiation Oncology, Hannover Medical School, Germany, Hannover, 30625
12Gynaecology Research Unit, Hannover Medical School, Germany, Hannover, 30625
PhDManjeet K. Bolla
13Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK, Cambridge, CB1 8RN
MScKristen Brantley
14Department of Epidemiology, Harvard T.H. Chan School of Public Health, USA, Boston, MA, 02115
Hermann Brenner
15Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Germany, Heidelberg, 69120
16German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Germany, Heidelberg, 69120
MDHelen Byers
17Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK, Manchester, M13 9WL
Nicola J. Camp
18Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, USA, Salt Lake City, UT, 84112
PhDJose E. Castelao
19Oncology and Genetics Unit, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, SERGAS, Spain, Vigo, 36312
MDMelissa H. Cessna
20Intermountain Healthcare, USA, Salt Lake City, UT, 84143
MDJenny Chang-Claude
9Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany, Heidelberg, 69120
21Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Germany, Hamburg, 20246
PhDStephen J. Chanock
3Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA, Bethesda, MD, 20850
MDGeorgia Chenevix-Trench
22Cancer Research Program, QIMR Berghofer Medical Research Institute Vol. Locked Bag 2000, Herston, QLD 4029, Australia, Brisbane, Queensland, 4006
PhDJi-Yeob Choi
23Department of Biomedical Sciences, Seoul National University Graduate School, Korea, Seoul, 03080
24Cancer Research Institute, Seoul National University, Korea, Seoul, 03080
25Institute of Health Policy and Management, Seoul National University Medical Research Center, Korea, Seoul, 03080
PhDSarah V. Colonna
18Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, USA, Salt Lake City, UT, 84112
MDKamila Czene
26Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden, Stockholm, 171 65
PhDMary B. Daly
27Department of Clinical Genetics, Fox Chase Cancer Center, USA, Philadelphia, PA, 19111
MDFrancoise Derouane
28Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Belgium, Leuven, 3000
Thilo Dörk
12Gynaecology Research Unit, Hannover Medical School, Germany, Hannover, 30625
PhDA. Heather Eliassen
14Department of Epidemiology, Harvard T.H. Chan School of Public Health, USA, Boston, MA, 02115
29Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, USA, Boston, MA, 02115
30Department of Nutrition, Harvard T.H. Chan School of Public Health, USA, Boston, MA, 02115
ScDChristoph Engel
31Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany, Leipzig, 04107
32LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Germany, Leipzig, 04103
MDMikael Eriksson
26Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden, Stockholm, 171 65
PhDD. Gareth Evans
17Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK, Manchester, M13 9WL
33North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, UK, Manchester, M13 9WL
MDOlivia Fletcher
34The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, UK, London, SW7 3RP
PhDLin Fritschi
35School of Population Health, Curtin University, Australia, Perth, Western Australia, 6102
PhDManuela Gago-Dominguez
36Cancer Genetics and Epidemiology Group, Genomic Medicine Group, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Spain, Santiago de Compostela, 15706
MDJeanine M. Genkinger
37Department of Epidemiology, Mailman School of Public Health, Columbia University, USA, New York, NY, 10032
38Herbert Irving Comprehensive Cancer Center, USA, New York, NY
Willemina R.R. Geurts-Giele
39Department of Clinical Genetics, Erasmus University Medical Center Vol. P.O. Box 2040, 3000 CA, the Netherlands, Rotterdam, 3015 CN
Gord Glendon
4Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Canada, Toronto, Ontario, M5G 1X5
MScPer Hall
26Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden, Stockholm, 171 65
40Department of Oncology, Södersjukhuset, Sweden, Stockholm, 118 83
PhDUte Hamann
41Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Germany, Heidelberg, 69120
PhDCecilia Y.S. Ho
42Department of Molecular Pathology, Hong Kong Sanatorium and Hospital, Hong Kong
Weang-Kee Ho
43School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Malaysia, Semenyih, Selangor, 43500
44Cancer Research Malaysia, Malaysia, Subang Jaya, Selangor, 47500
Maartje J. Hooning
39Department of Clinical Genetics, Erasmus University Medical Center Vol. P.O. Box 2040, 3000 CA, the Netherlands, Rotterdam, 3015 CN
45Department of Medical Oncology, Erasmus MC Cancer Institute Vol. P.O. Box 2040, 3000 CA, the Netherlands, Rotterdam, 3015 GD
PhDReiner Hoppe
46Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Germany, Stuttgart, 70376
47University of Tübingen, Germany, Tübingen, 72074
PhDAnthony Howell
48Division of Cancer Sciences, University of Manchester, UK, Manchester, M13 9PL
MBBSKeith Humphreys
26Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden, Stockholm, 171 65
PhD49Australian Breast Cancer Tissue Bank, Westmead Institute for Medical Research, University of Sydney, Australia, Sydney, New South Wales, 2145
50Research Department, Peter MacCallum Cancer Center, Australia, Melbourne, Victoria, 3000
51Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia, Parkville, Victoria, 3010
1Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore City, 138672
2Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore City, 117549
52Department of Surgery, National University Health System, Singapore, Singapore City, 119228
53Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore City, 119077
54Cancer Genetics Service, National Cancer Centre, Singapore, Singapore City, 169610
55Breast Department, KK Women’s and Children’s Hospital, Singapore, Singapore City, 229899
56SingHealth Duke-NUS Breast Centre, Singapore, Singapore City, 168753
57Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore City, 308433
58Division of Surgery and Surgical Oncology, National Cancer Centre, Singapore, Singapore City, 169610
59Department of General Surgery, Singapore General Hospital, Singapore, Singapore City, 169608
60Division of Breast Surgery, Department of General Surgery, Changi General Hospital, Singapore, Singapore City, 529889
61Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore City, 169610
62Division of Medical Oncology, National Cancer Centre, Singapore, Singapore City, 169610
43School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Malaysia, Semenyih, Selangor, 43500
44Cancer Research Malaysia, Malaysia, Subang Jaya, Selangor, 47500
63Breast Cancer Research Unit, University Malaya Cancer Research Institute, Faculty of Medicine, University of Malaya, Malaysia, Kuala Lumpur, 50603
Hidemi Ito
64Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Japan, Nagoya, 464-8681
65Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Japan, Nagoya, 466-8550
Motoki Iwasaki
66Division of Epidemiology, National Cancer Center Institute for Cancer Control, Japan, Tokyo, 104-0045
Anna Jakubowska
67Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Poland, Szczecin, 171-252
68International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Poland, Szczecin, 70-115
PhDHelena Jernström
8Oncology, Department of Clinical Sciences in Lund, Lund University, Sweden, Lund, 221 85
PhDEsther M. John
69Department of Epidemiology and Population Health, Stanford University School of Medicine, USA, Stanford, CA, 94305
70Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, USA, Stanford, CA, 94304
PhDNichola Johnson
34The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, UK, London, SW7 3RP
DPhilDaehee Kang
24Cancer Research Institute, Seoul National University, Korea, Seoul, 03080
71Department of Preventive Medicine, Seoul National University College of Medicine, Korea, Seoul, 03080
MDSung-Won Kim
72Department of Surgery, Daerim Saint Mary’s Hospital, Korea, Seoul, 07442
MDCari M. Kitahara
73Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA, Bethesda, MD, 20892
PhDYon-Dschun Ko
74Department of Internal Medicine, Johanniter GmbH Bonn, Johanniter Krankenhaus, Germany, Bonn, 53177
MDPeter Kraft
3Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA, Bethesda, MD, 20850
PhDAva Kwong
75Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong
76Department of Surgery, The University of Hong Kong, Hong Kong
77Department of Surgery and Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong
Diether Lambrechts
78Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Belgium, Leuven, 3000
79VIB Center for Cancer Biology, VIB, Belgium, Leuven, 3001
PhDSusanna Larsson
80Institute of Environmental Medicine, Karolinska Institutet, Sweden, Stockholm, 171 77
81Department of Surgical Sciences, Uppsala University, Sweden, Uppsala, 751 05
PhDShuai Li
13Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK, Cambridge, CB1 8RN
82Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Australia, Melbourne, Victoria, 3010
83Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Australia, Clayton, Victoria, 3168
PhDAnnika Lindblom
84Department of Molecular Medicine and Surgery, Karolinska Institutet, Sweden, Stockholm, 171 76
85Department of Clinical Genetics and Genomics, Karolinska University Hospital, Sweden, Stockholm, 171 76
MDMartha Linet
73Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA, Bethesda, MD, 20892
MDJolanta Lissowska
86Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Oncology Institute, Poland, Warsaw, 02-034
PhDArtitaya Lophatananon
87Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, UK, Manchester, M13 9PL
PhDRobert J. MacInnis
82Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Australia, Melbourne, Victoria, 3010
88Cancer Epidemiology Division, Cancer Council Victoria, Australia, Melbourne, Victoria, 3004
PhDArto Mannermaa
89Translational Cancer Research Area, University of Eastern Finland, Finland, Kuopio, 70210
90Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Finland, Kuopio, 70210
91Biobank of Eastern Finland, Kuopio University Hospital, Finland, Kuopio
PhDSiranoush Manoukian
92Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy, Milan, 20133
MDSara Margolin
40Department of Oncology, Södersjukhuset, Sweden, Stockholm, 118 83
93Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sweden, Stockholm, 118 83
MDKeitaro Matsuo
65Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Japan, Nagoya, 466-8550
94Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Japan, Nagoya, 464-8681
MDKyriaki Michailidou
13Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK, Cambridge, CB1 8RN
95Biostatistics Unit, The Cyprus Institute of Neurology and Genetics Vol. P.O.Box 23462, 1683, Nicosia, Cyprus, Cyprus, Nicosia, 2371
PhDRoger L. Milne
82Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Australia, Melbourne, Victoria, 3010
83Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Australia, Clayton, Victoria, 3168
88Cancer Epidemiology Division, Cancer Council Victoria, Australia, Melbourne, Victoria, 3004
PhDNur Aishah Mohd Taib
96Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Malaysia, Kuala Lumpur, 50603
MDKenneth Muir
87Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, UK, Manchester, M13 9PL
PhDRachel A. Murphy
97School of Population and Public Health, University of British Columbia, Canada, Vancouver, BC, V6T 1Z4
98Cancer Control Research, BC Cancer Agency, Canada, Vancouver, BC, V5Z 1L3
PhDWilliam G. Newman
17Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK, Manchester, M13 9WL
33North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, UK, Manchester, M13 9WL
Katie M. O’Brien
99Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, USA, Research Triangle Park, NC, 27709
PhDNadia Obi
100Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Germany, Hamburg, 20246
101Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Germany, Hamburg, 20246
PhDOlufunmilayo I. Olopade
102Center for Clinical Cancer Genetics, The University of Chicago, USA, Chicago, IL, 60637
Mihalis I. Panayiotidis
103Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics Vol. P.O.Box 23462, 1683, Nicosia, Cyprus, Cyprus, Nicosia, 2371
PhDSue K. Park
24Cancer Research Institute, Seoul National University, Korea, Seoul, 03080
71Department of Preventive Medicine, Seoul National University College of Medicine, Korea, Seoul, 03080
104Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Korea, Seoul, 03080
MDTjoung-Won Park-Simon
12Gynaecology Research Unit, Hannover Medical School, Germany, Hannover, 30625
MDAlpa V. Patel
10Department of Population Science, American Cancer Society, USA, Atlanta, GA, 30303
PhDPaolo Peterlongo
105Genome Diagnostics Program, IFOM ETS - the AIRC Institute of Molecular Oncology, Italy, Milan, 20139
PhDDijana Plaseska-Karanfilska
106Research Centre for Genetic Engineering and Biotechnology ‘Georgi D. Efremov’, MASA, Republic of North Macedonia, Skopje, 1000
PhDKatri Pylkäs
107Laboratory of Cancer Genetics and Tumor Biology, Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Finland, Oulu, 90220
108Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Finland, Oulu, 90220
PhDMuhammad U. Rashid
41Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Germany, Heidelberg, 69120
109Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Pakistan, Lahore, 54000
MDGad Rennert
110Faculty of Medicine, Technion – Israel Institute of Technology and Association for Promotion of Research in Precision Medicine, Israel, Haifa, 35254
MDJuan Rodriguez
26Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden, Stockholm, 171 65
PhDEmmanouil Saloustros
111Division of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Greece, Larissa, 411 10
MDDale P. Sandler
99Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, USA, Research Triangle Park, NC, 27709
PhDElinor J. Sawyer
112School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy’s Campus, King’s College London, UK, London
PhDChristopher G. Scott
113Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, USA, Rochester, MN, 55905
MSShamim Shahi
97School of Population and Public Health, University of British Columbia, Canada, Vancouver, BC, V6T 1Z4
PhDXiao-Ou Shu
114Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, USA, Nashville, TN, 37232
MDKaterina Shulman
115Clalit Regional Oncology Unit, Haifa and Western Galilee District, Israel, Haifa
MDJacques Simard
116Genomics Center, Centre Hospitalier Universitaire de Québec – Université Laval Research Center, Canada, Québec City, Québec, G1V 4G2
PhDMelissa C. Southey
83Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Australia, Clayton, Victoria, 3168
88Cancer Epidemiology Division, Cancer Council Victoria, Australia, Melbourne, Victoria, 3004
117Department of Clinical Pathology, The University of Melbourne, Australia, Melbourne, Victoria, 3010
PhDJennifer Stone
82Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Australia, Melbourne, Victoria, 3010
118Genetic Epidemiology Group, School of Population and Global Health, University of Western Australia, Australia, Perth, Western Australia, 6009
PhDJack A. Taylor
99Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, USA, Research Triangle Park, NC, 27709
119Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, USA, Research Triangle Park, NC, 27709
MDSoo-Hwang Teo
44Cancer Research Malaysia, Malaysia, Subang Jaya, Selangor, 47500
96Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Malaysia, Kuala Lumpur, 50603
PhDLauren R. Teras
10Department of Population Science, American Cancer Society, USA, Atlanta, GA, 30303
PhDMary Beth Terry
37Department of Epidemiology, Mailman School of Public Health, Columbia University, USA, New York, NY, 10032
PhDDiana Torres
41Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Germany, Heidelberg, 69120
120Institute of Human Genetics, Pontificia Universidad Javeriana, Colombia, Bogota, 110231
PhDCeline M. Vachon
121Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, USA, Rochester, MN, 55905
PhDMaxime Van Houdt
28Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Belgium, Leuven, 3000
Jelle Verhoeven
28Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Belgium, Leuven, 3000
Clarice R. Weinberg
122Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, USA, Research Triangle Park, NC, 27709
PhDAlicja Wolk
80Institute of Environmental Medicine, Karolinska Institutet, Sweden, Stockholm, 171 77
DrMedSciTaiki Yamaji
66Division of Epidemiology, National Cancer Center Institute for Cancer Control, Japan, Tokyo, 104-0045
Cheng Har Yip
96Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Malaysia, Kuala Lumpur, 50603
123Subang Jaya Medical Centre, Malaysia, Subang Jaya, Selangor, 47500
MDWei Zheng
114Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, USA, Nashville, TN, 37232
MDMikael Hartman
2Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore City, 117549
52Department of Surgery, National University Health System, Singapore, Singapore City, 119228
53Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore City, 119077
MDJingmei Li
1Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore City, 138672
53Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore City, 119077
124National Cancer Centre, Singapore, Singapore City, 168583
PhD
ABSTRACT
Background Breast cancer is multifactorial. Focusing on limited risk factors may miss high-risk individuals.
Methods We assessed the performance and overlap of various risk factors in identifying high-risk individuals for invasive breast cancer (BrCa) and ductal carcinoma in situ (DCIS) in 161,849 European-ancestry and 18,549 Asian-ancestry women. Discriminatory ability was evaluated using the area under the receiver operating characteristic curve (AUC). High-risk criteria included: 5-year absolute risk ≥1·66% by the Gail model [GAILbinary]; first-degree family history of breast cancer [FHbinary]; 5-year absolute risk ≥1·66% by a 313-variants polygenic risk score [PRSbinary]; and carriers of pathogenic variants in breast cancer predisposition genes [PTVbinary].
Findings The 5-year absolute risk by PRS outperformed the Gail model in predicting BrCa (Europeansvs controls: AUCPRS=0·635 [0·632-0·638] vs AUCGail=0·492 [0·489-0·495]; Asiansvs controls: AUCPRS=0·564 [0·556-0·573] vs AUCGail=0·506 [0·497-0·514]). PRSbinary and GAILbinary identified more high-risk European than Asia individuals. High-risk proportions were higher among BrCa (16-26%) and DCIS (20-33%) compared to controls (9-15%) among young Europeans and all Asians. Fewer than 7% of BrCa, 10% of DCIS, and 3% of controls were classified as high-risk by multiple risk classifiers. Overlap between PRSbinary and PTVbinary was minimal (<0·65% Europeans, <0·15% Asians) compared to the proportion at high risk using PTVbinary alone (Europeans: 4·6%, Asians: 4·4%) and PRSbinary alone (Europeans: 13·9%, Asians: 8·5%). PRSbinary and FHbinary uniquely identified 5-6% and 9-11% of young BrCa, respectively.
Interpretation The incomplete overlap between high-risk individuals identified by PRSbinary, GAILbinary, FHbinary, and PTVbinary highlights the need for a comprehensive approach to breast cancer risk prediction.
SIGNIFICANCE This study shows that different ways of predicting breast cancer risk do not always flag the same people, suggesting that combining multiple risk factors could improve early detection and screening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by the Agency for Science, Technology and Research (A*STAR) and PRECISION Health Research, Singapore (PRECISE). The breast cancer genome-wide association analyses in BCAC were supported by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, the Ministere de l'Economie, de la Science et de l'Innovation du Quebec through Genome Quebec and grant PSR-SIIRI-701, The National Institutes of Health (U19 CA148065, X01HG007492), Cancer Research UK (C1287/A10118, C1287/A16563, C1287/A10710), and The European Union (HEALTH-F2-2009-223175 and H2020 633784 and 634935). All studies and funders are listed in Additional Materials (BCAC Funding and Acknowledgments).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the A*STAR Institutional Review Board (reference number: 2022-041).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted March 03, 2025.
Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries
Peh Joo Ho, Christine Kim Yan Loo, Meng Huang Goh, Mustapha Abubakar, Thomas U. Ahearn, Irene L. Andrulis, Natalia N. Antonenkova, Kristan J. Aronson, Annelie Augustinsson, Sabine Behrens, Clara Bodelon, Natalia V. Bogdanova, Manjeet K. Bolla, Kristen Brantley, Hermann Brenner, Helen Byers, Nicola J. Camp, Jose E. Castelao, Melissa H. Cessna, Jenny Chang-Claude, Stephen J. Chanock, Georgia Chenevix-Trench, Ji-Yeob Choi, Sarah V. Colonna, Kamila Czene, Mary B. Daly, Francoise Derouane, Thilo Dörk, A. Heather Eliassen, Christoph Engel, Mikael Eriksson, D. Gareth Evans, Olivia Fletcher, Lin Fritschi, Manuela Gago-Dominguez, Jeanine M. Genkinger, Willemina R.R. Geurts-Giele, Gord Glendon, Per Hall, Ute Hamann, Cecilia Y.S. Ho, Weang-Kee Ho, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, ABCTB Investigators, kConFab Investigators, SGBCC Investigators, MyBrCa Investigators, Hidemi Ito, Motoki Iwasaki, Anna Jakubowska, Helena Jernström, Esther M. John, Nichola Johnson, Daehee Kang, Sung-Won Kim, Cari M. Kitahara, Yon-Dschun Ko, Peter Kraft, Ava Kwong, Diether Lambrechts, Susanna Larsson, Shuai Li, Annika Lindblom, Martha Linet, Jolanta Lissowska, Artitaya Lophatananon, Robert J. MacInnis, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, Keitaro Matsuo, Kyriaki Michailidou, Roger L. Milne, Nur Aishah Mohd Taib, Kenneth Muir, Rachel A. Murphy, William G. Newman, Katie M. O’Brien, Nadia Obi, Olufunmilayo I. Olopade, Mihalis I. Panayiotidis, Sue K. Park, Tjoung-Won Park-Simon, Alpa V. Patel, Paolo Peterlongo, Dijana Plaseska-Karanfilska, Katri Pylkäs, Muhammad U. Rashid, Gad Rennert, Juan Rodriguez, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Christopher G. Scott, Shamim Shahi, Xiao-Ou Shu, Katerina Shulman, Jacques Simard, Melissa C. Southey, Jennifer Stone, Jack A. Taylor, Soo-Hwang Teo, Lauren R. Teras, Mary Beth Terry, Diana Torres, Celine M. Vachon, Maxime Van Houdt, Jelle Verhoeven, Clarice R. Weinberg, Alicja Wolk, Taiki Yamaji, Cheng Har Yip, Wei Zheng, Mikael Hartman, Jingmei Li
medRxiv 2025.02.27.25323002; doi: https://doi.org/10.1101/2025.02.27.25323002
Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries
Peh Joo Ho, Christine Kim Yan Loo, Meng Huang Goh, Mustapha Abubakar, Thomas U. Ahearn, Irene L. Andrulis, Natalia N. Antonenkova, Kristan J. Aronson, Annelie Augustinsson, Sabine Behrens, Clara Bodelon, Natalia V. Bogdanova, Manjeet K. Bolla, Kristen Brantley, Hermann Brenner, Helen Byers, Nicola J. Camp, Jose E. Castelao, Melissa H. Cessna, Jenny Chang-Claude, Stephen J. Chanock, Georgia Chenevix-Trench, Ji-Yeob Choi, Sarah V. Colonna, Kamila Czene, Mary B. Daly, Francoise Derouane, Thilo Dörk, A. Heather Eliassen, Christoph Engel, Mikael Eriksson, D. Gareth Evans, Olivia Fletcher, Lin Fritschi, Manuela Gago-Dominguez, Jeanine M. Genkinger, Willemina R.R. Geurts-Giele, Gord Glendon, Per Hall, Ute Hamann, Cecilia Y.S. Ho, Weang-Kee Ho, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, ABCTB Investigators, kConFab Investigators, SGBCC Investigators, MyBrCa Investigators, Hidemi Ito, Motoki Iwasaki, Anna Jakubowska, Helena Jernström, Esther M. John, Nichola Johnson, Daehee Kang, Sung-Won Kim, Cari M. Kitahara, Yon-Dschun Ko, Peter Kraft, Ava Kwong, Diether Lambrechts, Susanna Larsson, Shuai Li, Annika Lindblom, Martha Linet, Jolanta Lissowska, Artitaya Lophatananon, Robert J. MacInnis, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, Keitaro Matsuo, Kyriaki Michailidou, Roger L. Milne, Nur Aishah Mohd Taib, Kenneth Muir, Rachel A. Murphy, William G. Newman, Katie M. O’Brien, Nadia Obi, Olufunmilayo I. Olopade, Mihalis I. Panayiotidis, Sue K. Park, Tjoung-Won Park-Simon, Alpa V. Patel, Paolo Peterlongo, Dijana Plaseska-Karanfilska, Katri Pylkäs, Muhammad U. Rashid, Gad Rennert, Juan Rodriguez, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Christopher G. Scott, Shamim Shahi, Xiao-Ou Shu, Katerina Shulman, Jacques Simard, Melissa C. Southey, Jennifer Stone, Jack A. Taylor, Soo-Hwang Teo, Lauren R. Teras, Mary Beth Terry, Diana Torres, Celine M. Vachon, Maxime Van Houdt, Jelle Verhoeven, Clarice R. Weinberg, Alicja Wolk, Taiki Yamaji, Cheng Har Yip, Wei Zheng, Mikael Hartman, Jingmei Li
medRxiv 2025.02.27.25323002; doi: https://doi.org/10.1101/2025.02.27.25323002
Subject Area
Subject Areas
- Addiction Medicine (430)
- Allergy and Immunology (756)
- Anesthesia (221)
- Cardiovascular Medicine (3298)
- Dermatology (280)
- Emergency Medicine (479)
- Epidemiology (13383)
- Forensic Medicine (19)
- Gastroenterology (899)
- Genetic and Genomic Medicine (5157)
- Geriatric Medicine (482)
- Health Economics (783)
- Health Informatics (3273)
- Health Policy (1143)
- Hematology (432)
- HIV/AIDS (1019)
- Medical Education (478)
- Medical Ethics (127)
- Nephrology (525)
- Neurology (4930)
- Nursing (262)
- Nutrition (730)
- Oncology (2524)
- Ophthalmology (727)
- Orthopedics (282)
- Otolaryngology (347)
- Pain Medicine (323)
- Palliative Medicine (90)
- Pathology (544)
- Pediatrics (1302)
- Primary Care Research (557)
- Public and Global Health (7511)
- Radiology and Imaging (1708)
- Respiratory Medicine (980)
- Rheumatology (480)
- Sports Medicine (424)
- Surgery (549)
- Toxicology (72)
- Transplantation (236)
- Urology (205)